Important information

Vimpat_CMI

For patients

The Consumer Medicine Information (CMI) provides clear, easy-to-understand information to consumers and their carer on what they need to know before, during and after taking their medicine. This CMI is specific to Australia and does not replace advice from a healthcare professional. If you have any questions or concerns about the CMI, please consult your doctor.

VIMPAT injection

VIMPAT tablets and oral solution

Vimpat_PI

For healthcare professionals

The Product Information (PI) is designed to support healthcare professionals in making informed treatment decisions and offering guidance on the proper use of this product. This information is intended exclusively for use in Australia.

VIMPAT injection

VIMPAT tablets and oral solution

Neither the CMI, nor the PI, are intended to promote any prescription product to the public.
VIMPAT® is a registered trademark used by UCB Pharma GmbH under license.
AU-VI-2400006. May 2025.